Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges
Related Experiment Video
Updated: Mar 2, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Lancelot J Millar1, Lei Shi1,2, Anna Hoerder-Suabedissen1
1Molnár Group, Department of Physiology, Anatomy and Genetics, University of OxfordOxford, UK.
Insights
Neonatal hypoxia-ischaemia (HI) causes significant disability. Investigating the subplate
Area of Science:
- Neuroscience
- Neonatal Medicine
- Developmental Biology
Background:
- Neonatal hypoxia-ischaemia (HI) is a leading cause of infant death and long-term neurological impairment.
- Advances in neonatal care increase survival but not neurological outcomes, leading to adult morbidity.
- Current therapeutic options for neonatal HI are limited.
Purpose of the Study:
- To review the biological mechanisms of neonatal HI.
- To explore the role of subplate-secreted molecules in neonatal HI.
- To evaluate animal models for studying neonatal HI.
Main Methods:
- Literature review of neonatal hypoxia-ischaemia.
- Analysis of subplate's secretory functions.
- Evaluation of existing animal models for HI research.
Main Results:
- The subplate, a transient cortical layer, has a significant secretory role.
- Subplate-secreted molecules represent potential therapeutic targets for HI.
- Neuroserpin is identified as a promising neuroprotective factor.
Conclusions:
- Subplate-secreted molecules offer novel therapeutic avenues for neonatal HI.
- Further research into neuroserpin could lead to new pharmacological interventions.
- Targeting the subplate may rescue brain development following neonatal HI.
Abstract:
Neonatal hypoxia-ischaemia (HI) is the most common cause of death and disability in human neonates, and is often associated with persistent motor, sensory, and cognitive impairment. Improved intensive care technology has increased survival without preventing neurological disorder, increasing morbidity throughout the adult population. Early preventative or neuroprotective interventions have the potential to rescue brain development in neonates, yet only one therapeutic intervention is currently licensed for use in developed countries. Recent investigations of the transient cortical layer known as subplate, especially regarding subplate's secretory role, opens up a novel set of potential molecular modulators of neonatal HI injury. This review examines the biological mechanisms of human neonatal HI, discusses evidence for the relevance of subplate-secreted molecules to this condition, and evaluates available animal models. Neuroserpin, a neuronally released neuroprotective factor, is discussed as a case study for developing new potential pharmacological interventions for use post-ischaemic injury.
